ADDLF (AddLife AB) Growth Rank: 8 (As of Aug. 04, 2026) — 11% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADDLF AddLife AB ADDLF
88 GF Score
Price $15.75
GF Value $15.15
! 5 Warning Signs
View Full Analysis

What is AddLife AB Growth Rank?

AddLife AB ADDLF 88 Growth Rank is 8 as of Aug. 04, 2026, which is 11% below its 10-year median of 9.00. GuruFocus rates ADDLF with a GF Score™ of 88/100 and a GF Value™ of $15.15. The stock has 5 warning signs investors should review.

AddLife AB has the Growth Rank of 8.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.


ADDLF vs ISRG, BDX, MDLN: Growth Rank Comparison

For the Medical Instruments & Supplies subindustry, AddLife AB's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AddLife AB Growth Rank vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AddLife AB's Growth Rank distribution charts can be found below:

* The bar in red indicates where AddLife AB's Growth Rank falls into.


ADDLF
88GF Score
AddLife AB ADDLF
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 8 mean?
AddLife AB (ADDLF) has a Growth Rank of 8 as of Aug. 04, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on AddLife AB and its competitors. This is 11% below median its historical median of 9.00. Over the past decade, AddLife AB's Growth Rank has ranged from 7.00 to 10.00.
Is AddLife AB's Growth Rank too high?
AddLife AB's current Growth Rank of 8 is 11% below median its 10-year median of 9.00. Over the past 10 years, this metric has ranged from a low of 7.00 to a high of 10.00. Overall, AddLife AB has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does AddLife AB's Growth Rank compare to ISRG and BDX?
AddLife AB's Growth Rank of 8 can be compared against companies in the Medical Devices & Instruments industry. Historically, AddLife AB's own Growth Rank has ranged from 7.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Medical Devices & Instruments company?
A good Growth Rank depends on the Medical Devices & Instruments industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on AddLife AB and its competitors. AddLife AB's current Growth Rank is 8, which is 11% below median its own 10-year median of 9.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AddLife AB stock overvalued right now?
AddLife AB (ADDLF) has a current Growth Rank of 8. The stock's GF Value™ is $15.15, compared to a current price of $15.75 — trading 4% above its estimated fair value. The current Growth Rank is 8, which is 11% below median its 10-year median of 9.00. AddLife AB's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For AddLife AB (ADDLF), the current Growth Rank is 8 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AddLife AB (ADDLF) Overvalued in 2026?

Based on GuruFocus' analysis, AddLife AB stock appears to be overvalued. The current stock price of $15.75 is trading 4% above its estimated GF Value™ of $15.15.

Key valuation signals for ADDLF:

  • Growth Rank: 8 (11% below median its 10-year median of 9.00)
  • GF Value™: $15.15 vs. price of $15.75 (4% above fair value)
  • GF Score™: 88/100 with 5 warning signs

No single metric tells the full story. See the ADDLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AddLife AB Business Description

Address Brunkebergstorg 5, Box 3145, Stockholm, SWE, 103 62
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech. The Labtech segment provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service to laboratories in medicine, research, academia and the food and pharmaceutical industries. The Medtech segment includes a range that spans from basic consumables to instruments for surgical procedures, welfare technology, and assistive devices for the elderly and disabled. The majority of revenue is derived from the Medtech segment.
88GF Score

Get the complete analysis for ADDLF

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.75
Price
$15.15
GF Value